Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

PRQRPRQR
Showing 8 of 26 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in PROQR THRAPEUTICS N V

CITADEL ADVISORS LLC holds 1.2M shares of PRQR (PROQR THRAPEUTICS N V), worth $2.2M as of 2026-Q2. The position was increased (+68.4% shares). PRQR represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$2.2M

Current Shares

1.2M

Total Value Change

+$2M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+68.4%
$2.2M0.0%$1.86
38
2026-Q1
Increased
703,323
+20.6%
$1.1M0.0%$1.50
30
2025-Q4
Decreased
583,222
-11.2%
$1.2M0.0%$2.00
0
2025-Q3
Increased
657,012
+73.2%
$1.4M0.0%$2.19
38
2025-Q2
Decreased
379,263
-53.7%
$773,6970.0%$2.04
0
2025-Q1
Increased
818,858
+100.3%
$1.1M0.0%$1.40
41
2024-Q4
Increased
408,807
+370.0%
$1.1M0.0%$2.65
41
2024-Q3
Increased
86,977
+373.6%
$158,2990.0%$1.83
25

Other major holders of PRQR: ADAGE CAPITAL PARTNERS GP, L.L.C., RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used